A 42-year-old man with a history of chronic diarrhea and malabsorption presents with angular cheilitis, glossitis, and seborrheic dermatitis of the nasolabial folds. Laboratory investigations show macrocytic anemia with hypersegmented neutrophils. Which single laboratory or clinical finding best distinguishes vitamin B₁₂ deficiency from folate deficiency in this patient?

Explanation

## Distinguishing Vitamin B₁₂ from Folate Deficiency: Biochemical Markers ### Overlapping vs. Discriminating Features | Feature | B₁₂ Deficiency | Folate Deficiency | **Discriminator?** | |---------|----------------|-------------------|--------------------| | **Macrocytic anemia** | ✓ (Yes) | ✓ (Yes) | ✗ (No — both present) | | **Hypersegmented neutrophils** | ✓ (Yes) | ✓ (Yes) | ✗ (No — both present) | | **Glossitis, angular cheilitis** | ✓ (Yes) | ✓ (Yes) | ✗ (No — both present) | | **Seborrheic dermatitis** | ✓ (Yes) | ✓ (Yes) | ✗ (No — both present) | | **Methylmalonic acid (MMA)** | ↑↑ **Elevated** | **Normal** | ✓ **YES — KEY DISCRIMINATOR** | | **Homocysteine** | ↑↑ **Elevated** | ↑ Elevated | ✓ **YES — SUPPORTS B₁₂** | | **Neurological signs** (paresthesia, ataxia, subacute combined degeneration) | ✓ (Yes) | ✗ (No) | ✓ **YES — if present** | **Key Point:** Both B₁₂ and folate deficiency cause identical hematologic findings (macrocytic anemia, hypersegmented neutrophils) and overlapping cutaneous/mucosal signs. **Elevated methylmalonic acid (MMA) is pathognomonic for B₁₂ deficiency** because MMA accumulates when methylmalonyl-CoA mutase (a B₁₂-dependent enzyme) is blocked. ### Why MMA is the Best Discriminator 1. **B₁₂ deficiency** → Blocks methylmalonyl-CoA mutase → MMA accumulates → **MMA elevated** 2. **Folate deficiency** → Does NOT affect this pathway → **MMA normal** 3. **Homocysteine** is elevated in both (because both B₁₂ and folate are needed for remethylation), but MMA is specific to B₁₂ **High-Yield:** **Elevated MMA + elevated homocysteine = B₁₂ deficiency**; **Normal MMA + elevated homocysteine = folate deficiency** [cite:Harrison 21e Ch 96] **Clinical Pearl:** Neurological signs (subacute combined degeneration, peripheral neuropathy, ataxia) are a clinical discriminator if present, but they develop late and are not always present. Biochemical markers are more reliable. ### Mnemonic **MMA = B₁₂** (Methylmalonic acid elevated only in B₁₂ deficiency) ### Metabolic Basis ```mermaid flowchart TD A[Vitamin B₁₂ Deficiency]:::outcome --> B[Methylmalonyl-CoA mutase blocked]:::action B --> C[Methylmalonic acid accumulates]:::urgent C --> D[Elevated MMA in serum/urine]:::outcome E[Folate Deficiency]:::outcome --> F[Methylmalonyl-CoA mutase functional]:::action F --> G[Methylmalonic acid normal]:::outcome H[Both deficiencies]:::outcome --> I[Impaired remethylation]:::action I --> J[Elevated homocysteine]:::outcome ```